Biopharmaceutical multinational AstraZeneca is not letting a bumpy 2024 dictate its path forward in China, and in the wake of…
Read More »AstraZeneca
British-Swedish pharmaceutical giant AstraZeneca endured a torrid time in China last year, as it underwent several investigations and saw one…
Read More »
China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »